在全州质量协作范围内实现足够的肺癌手术淋巴结清扫:质量改进的实践
2016年1月起,一个全州质量改进协作组针对肺癌手术中足够淋巴结采集的3项指标(检查10枚及以上淋巴结的比例、采样5个及以上肺门或纵隔淋巴结站的比例、病理淋巴结降期)开展干预,在双年会上公布医院层面非盲法结果并讨论教育或改进机会。回顾性分析2015年7月至2020年12月16个参与中心因IA-IIIA期非小细胞肺癌行肺叶切除术的患者。结果显示检查10枚及以上淋巴结的比例从2015年215例(44.0%)升至2020年522例(78.9%)(P < .001),采样5个及以上淋巴结站的比例从193例(39.6%)升至2020年531例(80.3%)(P < .001),总体淋巴结降期率逐年波动且总体随时间下降(P = .004)。
要点
- 全州质量改进协作使检查10枚及以上淋巴结的肺叶切除术比例从2015年44.0%升至2020年78.9%(P < .001)。
- 采样5个及以上淋巴结站的比例从2015年39.6%升至2020年80.3%(P < .001)。
- 总体淋巴结降期率逐年波动且总体随时间下降(P = .004)。
核心结论
- 全州质量改进协作改善了手术治疗非小细胞肺癌的适当淋巴结分期率,优于全国率。
- 透明数据驱动的讨论和协作可指导未来质量改进举措,并应易于转移到其他临床领域。
研究设计与样本
- 回顾性审查2015年7月至2020年12月在16个参与中心因IA至IIIA期非小细胞肺癌行肺叶切除术的患者。
- 全州质量改进协作于2016年1月启动,聚焦3项足够淋巴结采集指标:检查10枚及以上淋巴结的比例、采样5个及以上肺门或纵隔淋巴结站的比例、病理淋巴结降期。
- 在双年会上公布医院层面非盲法结果,并讨论教育或改进机会。
主要发现
- 研究队列包括3753例患者。
- 全州检查10枚及以上淋巴结的肺叶切除术从2015年215例(44.0%)增至2020年522例(78.9%)(P < .001)。
- 全州采样5个及以上淋巴结站的肺叶切除术从2015年193例(39.6%)增至2020年531例(80.3%)(P < .001)。
- 总体淋巴结降期率逐年波动更大,且总体随时间下降(P = .004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In January 2016, our statewide quality improvement collaborative focused on 3 metrics of adequate lymph node harvest during lung cancer surgery: (1) rates of pathologic examination of 10 lymph nodes or more; (2) sampling 5 or more lymph node stations or more within the hilum or mediastinum; and (3) pathologic nodal upstaging (pathologic nodal stage higher than clinical nodal stage). Unblinded, hospital-level outcomes were presented at biannual meetings, and opportunities for education or improvement were discussed. We set out to describe this quality improvement initiative and the subsequent impact on surgical lymphadenectomies statewide. METHODS: We retrospectively reviewed patients undergoing lobectomy for stage IA to IIIA non-small-cell lung cancer from July 2015 to December 2020 at the 16 participating centers. RESULTS: The study cohort included 3753 patients. The rates of examining 10 lymph nodes or more statewide increased from 215 lobectomies (44.0%) in 2015 to 522 lobectomies (78.9%) in 2020 (P < .001). Similar trends were noted statewide for 5 lymph node stations or more, which increased from 193 lobectomies (39.6%) to 531 lobectomies (80.3%) in 2020 (P < .001). The overall rate of nodal upstaging was more variable year to year and generally declined over time (P = .004). CONCLUSIONS: Our statewide quality improvement initiative improved rates of appropriate lymph node staging for surgically treated non-small cell lung cancer compared with national rates. This work demonstrates the power that a "community of practice" philosophy can have on surgical treatment of lung cancer. Quality improvement interventions including transparent data-driven discussions and collaboration can help guide future quality improvement initiatives and should be readily transferrable to other clinical domains.
引用
- Kalata S, Lam GT, Alnajjar RM, et al. Adequate lung cancer surgery lymphadenectomy within a statewide quality collaborative: Quality improvement in action. J Thorac Cardiovasc Surg. 2022. PMID: 36456358. doi:10.1016/j.jtcvs.2022.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。